Vaccine News and Research

Latest Vaccine News and Research

Staggered local re-openings could be the best COVID-19 exit strategy

When a new infectious disease appears, the lack of an effective treatment or vaccine strategy often results in the application of non-pharmacological interventions (NPIs) or containment measures, including testing for infection, tracing contacts, and isolating potential sources of infection.

17 May 2020

Inadequate vaccine and epidemic control in the US

A new paper published on the preprint server medRxiv* in May 2020 shows that vaccination must be combined with nonpharmacological interventions (NPIs) to achieve rapid and effective control of the ongoing pandemic.

17 May 2020

Researchers investigate safety of convalescent plasma for COVID-19

The current pandemic of COVID-19 seems to be slowing down in various parts of the world, but is far from controlled, as incidence rates rise in new regions. In the absence of an effective vaccine or therapeutic drug, scientists have relied on supportive medical care to treat the sick.

17 May 2020

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

US researchers have published a proof of concept on the efficacy of human monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in laboratory conditions, as well as their pioneering use in a mouse model. The study is available on the preprint server bioRxiv*.

17 May 2020

New algorithm could help investigate the genetic clues behind immunity

Scientists with UC San Diego's Jacobs School of Engineering and the Qualcomm Institute have developed a new gene prediction algorithm, called MINING-D, that could help researchers investigate the genetic clues behind the variation of symptoms shown in COVID-19 patients - information that is key to creating a versatile and effective vaccine.

15 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

The Networks of Centres of Excellence recently announced its continued support in Canadian glycomics research with a three-year investment of $16.3 million through the Canadian Glycomics Network (GlycoNet).

15 May 2020

A measured approach to relaxation of COVID-19 lockdown measures may be necessary

A cautious, measured approach to relaxation of lockdown measures is required to protect the most vulnerable members of society and support the health service, a team of infectious disease experts from the University of Warwick, who have investigated the impact of current lockdown measures upon the spread of COVID-19 in the UK, has found.

15 May 2020

Media representations are changing to reflect new public attitudes toward autism

The Washington Post's depiction of autism has shifted over the years from a focus on "cause and cure" toward one of acceptance and accommodation, say the authors of a study that examined 315 articles published from 2007 to 2017.

15 May 2020

Chasing the elusive dream of a COVID cure

Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.

15 May 2020

First cellular immunology data to help guide social distancing recommendations

Scientists around the world are racing to develop a vaccine to protect against COVID-19 infection, and epidemiologists are trying to predict how the coronavirus pandemic will unfold until such a vaccine is available.

15 May 2020

HVTN and HPTN initiate first clinical trial in response to COVID-19

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19.

15 May 2020

Research investigates COVID-19 virus origin using artificial intelligence (AI)

The coronavirus responsible for the COVID-19 pandemic has spread across the globe with unprecedented speed and lethality, killing hundreds of thousands of people and forcing countries’ entire populations to self-quarantine.

15 May 2020

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

In an article published today in Cell Host and Microbe, Professor Kanta Subbarao stressed the importance of detecting a neutralizing antibody response in recovered COVID-19 patients, and of studies of COVID-19 vaccines in animal models.

15 May 2020

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

Scientists from the Walter Reed Army Institute of Research joined partners at Duke University, Florida Atlantic University and Montana State University to publish a study providing clear evidence that malaria's characteristic cycle of fever and chills is a result of the parasite's own influence--not factors from the host.

15 May 2020

A road map to find unanswered questions about COVID-19

There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.

15 May 2020

Continuously active antiviral coating may reduce the spread of COVID-19

Surfaces coated with a quaternary ammonium polymer have remarkable antiviral properties. They may even be capable of reducing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in areas with high risk for contamination, such as indoor environments or public places. University of Arizona researchers explain the antiviral potential of these in a new study published on the preprint server medRxiv.

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

14 May 2020

Low-cost PCR test designed to detect coronavirus

The project of Consuelo Rubio has been among those chosen for the call of the Valencian System of Innovation and Research for the COVID-19 emergency.

14 May 2020

Vaccine News and Research

Latest Vaccine News and Research

Staggered local re-openings could be the best COVID-19 exit strategy

Inadequate vaccine and epidemic control in the US

Researchers investigate safety of convalescent plasma for COVID-19

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

New algorithm could help investigate the genetic clues behind immunity

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

A measured approach to relaxation of COVID-19 lockdown measures may be necessary

Media representations are changing to reflect new public attitudes toward autism

Chasing the elusive dream of a COVID cure

First cellular immunology data to help guide social distancing recommendations

HVTN and HPTN initiate first clinical trial in response to COVID-19

Research investigates COVID-19 virus origin using artificial intelligence (AI)

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

Malaria's characteristic cycle of fever and chills is a result of parasite's own influence

A road map to find unanswered questions about COVID-19

Continuously active antiviral coating may reduce the spread of COVID-19

ACTG initiates clinical trial to evaluate treatment for COVID-19

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

Low-cost PCR test designed to detect coronavirus

eBook: Advancing infectious disease vaccine development eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Vaccine News and Research

Latest Vaccine News and Research

eBook: Advancing infectious disease vaccine development eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in